Pancreatic Cancer Research

ResearcherZhengzhou UniversityActive in the last 2 years

Pengju Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1046-6360; OpenAlex author ID A5100604929. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer. Last author DOI 10.3389/fimmu.2024.1506632↗
  2. A vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0464↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yaohe Wang · 2 shared papers, 2015–2024 · strength 0.23
  2. Yujing Xuan · 1 shared paper, 2024 · strength 0.18
  3. Wenyi Yan · 1 shared paper, 2024 · strength 0.18
  4. Lingling Si · 1 shared paper, 2024 · strength 0.18
  5. Eleni Maniati · 1 shared paper, 2015 · strength 0.04
  6. Louisa S. Chard · 1 shared paper, 2015 · strength 0.04
  7. Thorsten Hagemann · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.